We partner with technology leaders to unlock next levels of growth & success.
>Explore our advisory services. >See some of the strategic transactions we have led to success. >Learn why we made an early commitment to Tessian and >how Institut Pasteur’s PathoQuest has won backing for post-pandemic expansion in the U.S.
Incision raises €5M for surgical training platform
Fraser makes early commitment to Spearad
Charles River and PathoQuest strengthen partnership
Welcome Dr. Clemens Gocke to our Advisory Board
m-pathy has been acquired by Verint Systems
Tessian raises $65M to advance security at the human layer
The Series C round was led by March Capital alongside existing investors Balderton, Latitude, Sequoia Capital and Accel, and new investor Schroder Adveq. With the new funding, Tessian will expand its platform’s capabilities, helping companies replace their secure email gateways and legacy data loss prevention solutions.
Fraser, through its partners and affiliates, made an early commitment to Tessian, participating in pre-Seed, Seed and Series A rounds, and serving on the Company’s board 2015-16.
We advise entrepreneurs, senior management and boards on their most important strategic decisions and transactions. We are building true partnerships and are deeply invested in every business we take on.
Navigating the transformational forces in the digital economy
We focus on enterprise technology, digital-first services, and digital health & life sciences. We leverage our domain expertise, transaction record, and connectivity, to navigate and capitalize on the transformational forces affecting the industry.
Unlocking next levels of
growth & success
We help great businesses scale and drive exceptional value for shareholders, management and employees. Many have been recognized as growth leaders in their sector and have been backed by top technology investors or acquired, at premium valuations, by global strategic buyers.